Approval · Notice of Compliance 10784 · 2009
FIRMAGON: Notice of Compliance 10784
Issued November 16, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10784
- Date
- November 16, 2009
- Company
- Ferring Inc.North York, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Gonadotropin-releasing hormone receptor antagonist
Products in this notice
Medicinal ingredients
- DEGARELIX ACETATE 80 MG per VIAL
- DEGARELIX ACETATE 120 MG per VIAL